(Q37378564)

20 August 2017

1 reference

title

Glycemic risk factors of diabetic vascular complications: the role of glycemic variability (English)

1 reference

20 August 2017

3

Giovanni Ghirlanda

0 references

Dario Pitocco

2

object named as

Dario Pitocco

0 references

Francesco Zaccardi

1

object named as

Francesco Zaccardi

0 references

author name string

Francesco Zaccardi

1

1 reference

PubMed ID

19172575

20 August 2017

Dario Pitocco

2

1 reference

PubMed ID

19172575

20 August 2017

Giovanni Ghirlanda

3

1 reference

20 August 2017

1 March 2009

1 reference

Diabetes - Metabolism: Research and Reviews

20 August 2017

1 reference

20 August 2017

25

1 reference

20 August 2017

3

1 reference

20 August 2017

199-207

1 reference

Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).

20 August 2017

1 reference

Impaired glucose tolerance and the likelihood of nonfatal stroke and myocardial infarction: the Third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors

21 January 2018

1 reference

Economic costs of diabetes in the US in 2002.

21 January 2018

1 reference

7 January 2021

The costs of non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

7 January 2021

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

7 January 2021

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

7 January 2021

Impaired fasting glucose and impaired glucose tolerance: implications for care

1 reference

7 January 2021

Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies

1 reference

7 January 2021

Dysglycaemia and risk of cardiovascular disease

1 reference

7 January 2021

Is there a glycemic threshold for mortality risk?

1 reference

7 January 2021

Impaired fasting glucose: how low should it go?

1 reference

7 January 2021

A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study.

1 reference

7 January 2021

Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in Diabetes

1 reference

7 January 2021

Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients

1 reference

7 January 2021

The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

1 reference

7 January 2021

Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes

1 reference

7 January 2021

Angiographic coronary artery disease is associated with progressively higher levels of fasting plasma glucose.

1 reference

7 January 2021

Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61.

1 reference

7 January 2021

Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design

1 reference

7 January 2021

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.

1 reference

7 January 2021

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

1 reference

7 January 2021

Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study

1 reference

7 January 2021

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

7 January 2021

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

7 January 2021

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

1 reference

7 January 2021

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

1 reference

7 January 2021

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

7 January 2021

Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts.

1 reference

7 January 2021

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

7 January 2021

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

7 January 2021

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

7 January 2021

Studies of an unusual hemoglobin in patients with diabetes mellitus

1 reference

7 January 2021

Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus

1 reference

7 January 2021

The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo

1 reference

7 January 2021

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

1 reference

7 January 2021

Relationship between glycated haemoglobin levels and mean glucose levels over time

1 reference

7 January 2021

Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins.

1 reference

7 January 2021

Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes

1 reference

7 January 2021

The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial

1 reference

7 January 2021

The pathobiology of diabetic complications: a unifying mechanism

1 reference

7 January 2021

Postprandial hyperglycemia and diabetes complications: is it time to treat?

1 reference

7 January 2021

Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture

1 reference

7 January 2021

Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation

1 reference

7 January 2021

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

1 reference

7 January 2021

Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.

1 reference

7 January 2021

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients

1 reference

7 January 2021

A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial

1 reference

7 January 2021

THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS

1 reference

7 January 2021

Quality control of intensified insulin therapy: HbA1 versus blood glucose

1 reference

7 January 2021

"J"-index. A new proposition of the assessment of current glucose control in diabetic patients.

1 reference

7 January 2021

Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability

1 reference

7 January 2021

Day-to-day variation of continuously monitored glycaemia: A further measure of diabetic instability

1 reference

7 January 2021

A novel approach to continuous glucose analysis utilizing glycemic variation.

1 reference

7 January 2021

A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus

1 reference

7 January 2021

Evaluation of a new measure of blood glucose variability in diabetes

1 reference

7 January 2021

Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index

1 reference

7 January 2021

Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes

1 reference

7 January 2021

A method for assessing quality of control from glucose profiles.

1 reference

7 January 2021

Sudden cardiac death: influence of diabetes

1 reference

7 January 2021

Glycemic targets and cardiovascular disease

1 reference

7 January 2021

Glycemic variability: should we and can we prevent it?

1 reference

7 January 2021

Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina.

1 reference

7 January 2021

Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.938

1 reference

20 August 2017

1 reference

PubMed ID

19172575